Global Digital Therapeutics in Mental Health Market - 2026-2033

April 2026 | 70 pages | ID: G369AD74A751EN
DataM Intelligence

Abstracts

Global Digital Therapeutics in Mental Health Market reached US$ 3.67 billion in 2025 and is expected to reach US$ 18.13 billion by 2033, growing with a CAGR of 19.60% during the forecast period 2026-2033.

The Global Digital Therapeutics in Mental Health Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Global Digital Therapeutics in Mental Health Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Type

• Software-Based Digital Therapeutics*
• Mobile Apps
• Web-based Programs
• AI-powered Chatbots
• Hardware-Integrated Digital Therapeutics
• Wearable Devices
• Virtual Reality (VR) & Augmented Reality (AR) Solutions
• Sensor-based Digital Therapeutics
• Biometric Sensors
• Motion Sensors for Behavioral Monitoring

By Application

• Depression & Mood Disorders*
• Anxiety Disorders
• Post-Traumatic Stress Disorder
• Obsessive-Compulsive Disorder (OCD)
• Schizophrenia & Psychotic Disorders
• Sleep Disorders & Insomnia
• Substance Use Disorders
• Attention-Deficit/Hyperactivity Disorder (ADHD)
• Others

Regional Analysis for Global Digital Therapeutics in Mental Health Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Global Digital Therapeutics in Mental Health Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY TYPE

4.1. Snippet by Application
4.2. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Shift Towards Digital Mental Health Solutions
    5.1.1.2. Rising Mental Health Crisis & Demand for Scalable Solutions
    5.1.1.3. XX
  5.1.2. Restraints
    5.1.2.1. Data Privacy & Cybersecurity Concerns
    5.1.2.2. Limited Regulatory Clarity & Approval Bottlenecks
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Rising Technological Advancements
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established Leaders with Largest Marketing Brand
  6.1.3. Market Leaders with Established Products
6.2. Latest Developments and Breakthroughs
6.3. Regulatory and Reimbursement Landscape
  6.3.1. North America
  6.3.2. Europe
  6.3.3. Asia Pacific
  6.3.4. Latin America
  6.3.5. Middle East & Africa
6.4. Porter’s Five Forces Analysis
6.5. Supply Chain Analysis
6.6. Patent Analysis
6.7. SWOT Analysis
6.8. Unmet Needs and Gaps
6.9. Recommended Strategies for Market Entry and Expansion
6.10. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.11. Pricing Analysis and Price Dynamics
6.12. Key Opinion Leaders

7. DIGITAL THERAPEUTICS IN MENTAL HEALTH MARKET, BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type
7.2. Software-Based Digital Therapeutics*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  7.2.3. Mobile Apps
  7.2.4. Web-based Programs
  7.2.5. AI-powered Chatbots
7.3. Hardware-Integrated Digital Therapeutics
  7.3.1. Wearable Devices
  7.3.2. Virtual Reality (VR) & Augmented Reality (AR) Solutions
7.4. Sensor-based Digital Therapeutics
  7.4.1. Biometric Sensors
  7.4.2. Motion Sensors for Behavioral Monitoring

8. DIGITAL THERAPEUTICS IN MENTAL HEALTH MARKET, BY APPLICATION

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  8.1.2. Market Attractiveness Index, By Application
8.2. Depression & Mood Disorders*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Anxiety Disorders
8.4. Post-Traumatic Stress Disorder
8.5. Obsessive-Compulsive Disorder (OCD)
8.6. Schizophrenia & Psychotic Disorders
8.7. Sleep Disorders & Insomnia
8.8. Substance Use Disorders
8.9. Attention-Deficit/Hyperactivity Disorder (ADHD)
8.10. Others

9. DIGITAL THERAPEUTICS IN MENTAL HEALTH MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    9.1.1.1. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.5.1. U.S.
    9.2.5.2. Canada
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.5.1. Germany
    9.3.5.2. UK
    9.3.5.3. France
    9.3.5.4. Spain
    9.3.5.5. Italy
    9.3.5.6. Rest of Europe
9.4. Latin America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.5.1. Mexico
    9.4.5.2. Brazil
    9.4.5.3. Argentina
    9.4.5.4. Rest of South America
9.5. Asia-Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.5.1. China
    9.5.5.2. India
    9.5.5.3. Japan
    9.5.5.4. South Korea
    9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

10.1. Competitive Overview and Key Market Players
  10.1.1. Market Share Analysis and Positioning Matrix
  10.1.2. Strategic Partnerships, Mergers & Acquisitions
  10.1.3. Key Developments in Product Portfolios and Innovations
  10.1.4. Company Benchmarking

11. COMPANY PROFILES

11.1. FBigHealth*
  11.1.1. Company Overview
  11.1.2. Product Portfolio
    11.1.2.1. Product Description
    11.1.2.2. Product Key Performance Indicators (KPIs)
    11.1.2.3. Historic and Forecasted Product Sales
    11.1.2.4. Product Sales Volume
  11.1.3. Financial Overview
    11.1.3.1. Company Revenue
      11.1.3.1.1. Geographical Revenue Shares
        11.1.3.1.1.1. Revenue Forecasts
      11.1.3.1.2. Key Developments
        11.1.3.1.2.1. Mergers & Acquisitions
        11.1.3.1.2.2. Key Product Development Activities
        11.1.3.1.2.3. Regulatory Approvals, etc.
      11.1.3.1.3. SWOT Analysis
11.2. Click Therapeutics, Inc.
11.3. Welldoc, Inc.
11.4. 2Morrow Inc.
11.5. Mindscapes
11.6. Calm.com, Inc.
11.7. MoodMission Pty Ltd
11.8. Boehringer Ingelheim Pharmaceuticals, Inc.
11.9. Headspace Inc.
11.10. Happify, Inc. (LIST NOT EXHAUSTIVE)

12. ASSUMPTION AND RESEARCH METHODOLOGY

12.1. Data Collection Methods
12.2. Data Triangulation
12.3. Forecasting Techniques
12.4. Data Verification and Validation

13. APPENDIX

13.1. About Us and Services
13.2. Contact Us
For more Healthcare IT-related reports, please click here (https://www.datamintelligence.com/industry-verticals/healthcare-it)